Aspirin in the Management of Patients with Prostate Cancer Undergoing Radiotherapy: Friend or Foe?

Aspirin has cyclooxygenase-2 (COX2)-mediated anti-inflammatory and anti-coagulant properties that may confer a positive effect in preventing and limiting the progression of prostate cancer. Prostate cancer has been shown to have poor treatment outcomes due to therapeutic resistance; therefore, COX2 inhibition caused by aspirin could represent an opportunity to augment current therapies. This is particularly of interest to patients undergoing radiation therapy (RT) where inflammation is a common side-effect. This review discusses the evidence for the potential role of aspirin in the management of patients with prostate cancer undergoing RT.

Anticancer research. 2018 Apr [Epub]

Bianca Mascan, Laure Marignol

Applied Radiation Therapy Trinity, Discipline of Radiation therapy, Trinity College, Dublin, Ireland., Applied Radiation Therapy Trinity, Discipline of Radiation therapy, Trinity College, Dublin, Ireland .

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe